Recruiting CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies NCT05442515 Conditions Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Lymphoid Leukemia, +34 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Completed Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies NCT02315612 Conditions ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Completed Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab NCT03480438 Conditions B-precursor ALL, Burkitt Lymphoma, DNA Virus Infections, +15 more Locations University Hospital of Frankfurt (Main) — Frankfurt am Main, Hesse, Germany Uniklinik RWTH Aachen — Aachen, Germany Charité - Campus Benjamin Franklin — Berlin, Germany Vivantes Klinikum Neukölln — Berlin, Germany View all 21 locations View more locations Show fewer locations Loading locations... View Trial Details
